Systematically comparing COVID-19 with the 2009 influenza pandemic for hospitalized patients
- PMID: 33189938
- PMCID: PMC7658594
- DOI: 10.1016/j.ijid.2020.11.127
Systematically comparing COVID-19 with the 2009 influenza pandemic for hospitalized patients
Abstract
Objectives: This study aimed to comprehensively compare the clinical features of hospitalized COVID-19 patients with hospitalized 2009 influenza pandemic patients.
Methods: Medline, Embase, Web of Science, Cochrane CENTRAL, and Google scholar were systematically searched to identify studies related to COVID-19 and the 2009 influenza pandemic. The pooled incidence rates of clinical features were estimated using the DerSimonian-Laird random-effects model with the Freeman-Tukey double arcsine transformation method.
Results: The incidence rates of fever, cough, shortness of breath, sore throat, rhinorrhea, myalgia/muscle pain, or vomiting were found to be significantly higher in influenza patients when compared with COVID-19 patients. The incidence rates of comorbidities, including cardiovascular disease/hypertension and diabetes, were significantly higher in COVID-19 compared with influenza patients. In contrast, comorbidities such as asthma, chronic obstructive pulmonary disease, and immunocompromised conditions were significantly more common in influenza compared with COVID-19 patients. Unexpectedly, the estimated rates of intensive care unit admission, treatment with extracorporeal membrane oxygenation, treatment with antibiotics, and fatality were comparable between hospitalized COVID-19 and 2009 influenza pandemic patients.
Conclusions: This study comprehensively estimated the differences and similarities of the clinical features and burdens of hospitalized COVID-19 and 2009 influenza pandemic patients. This information will be important to better understand the current COVID-19 pandemic.
Keywords: 2009 influenza pandemic; COVID-19; Clinical features; Comorbidities; Meta-analysis; Symptoms.
Copyright © 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Figures
Similar articles
-
A Comparative Systematic Review of COVID-19 and Influenza.Viruses. 2021 Mar 10;13(3):452. doi: 10.3390/v13030452. Viruses. 2021. PMID: 33802155 Free PMC article.
-
Comparison of the clinical characteristics and outcomes of hospitalized adult COVID-19 and influenza patients - a prospective observational study.Infect Dis (Lond). 2021 Feb;53(2):111-121. doi: 10.1080/23744235.2020.1840623. Epub 2020 Nov 10. Infect Dis (Lond). 2021. PMID: 33170050
-
Comparison of Clinical Features of COVID-19 vs Seasonal Influenza A and B in US Children.JAMA Netw Open. 2020 Sep 1;3(9):e2020495. doi: 10.1001/jamanetworkopen.2020.20495. JAMA Netw Open. 2020. PMID: 32897374 Free PMC article.
-
Comparison of patients hospitalized with COVID-19, H7N9 and H1N1.Infect Dis Poverty. 2020 Dec 2;9(1):163. doi: 10.1186/s40249-020-00781-5. Infect Dis Poverty. 2020. PMID: 33261654 Free PMC article.
-
Comparison of the clinical differences between COVID-19, SARS, influenza, and the common cold: A systematic literature review.Adv Clin Exp Med. 2021 Jan;30(1):109-114. doi: 10.17219/acem/129573. Adv Clin Exp Med. 2021. PMID: 33529514
Cited by
-
A Comparative Systematic Review of COVID-19 and Influenza.Viruses. 2021 Mar 10;13(3):452. doi: 10.3390/v13030452. Viruses. 2021. PMID: 33802155 Free PMC article.
-
Expression of Surfactant Protein D Distinguishes Severe Pandemic Influenza A(H1N1) from Coronavirus Disease 2019.J Infect Dis. 2021 Jul 2;224(1):21-30. doi: 10.1093/infdis/jiab113. J Infect Dis. 2021. PMID: 33668070 Free PMC article.
-
Epidemiology and Clinical Characteristics of Laboratory-Confirmed COVID-19 and Influenza Infections in Children: A 2015-2024 Study in Taiwan.Microorganisms. 2025 Feb 26;13(3):517. doi: 10.3390/microorganisms13030517. Microorganisms. 2025. PMID: 40142409 Free PMC article.
-
Impact of SARS-CoV-2 on Viral Respiratory Infections in Patients with Hematological Malignancies.Viruses. 2024 Sep 26;16(10):1520. doi: 10.3390/v16101520. Viruses. 2024. PMID: 39459855 Free PMC article.
-
Inhaled corticosteroids do not adversely impact outcomes in COVID-19 positive patients with COPD: An analysis of Cleveland Clinic's COVID-19 registry.PLoS One. 2021 Jun 3;16(6):e0252576. doi: 10.1371/journal.pone.0252576. eCollection 2021. PLoS One. 2021. PMID: 34081722 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical